title: [Acute myeloblastic leukemia 5q-. Clinical and cytogenetic remission by means of intensive chemotherapy].
authors.forename: G
authors.initials: G
authors.lastname: Las Heras
authors.forename: J M
authors.initials: JM
authors.lastname: Ribera
authors.forename: I
authors.initials: I
authors.lastname: Granada
authors.forename: F
authors.initials: F
authors.lastname: Millá
mesh_terms: D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5 / Q000648:ultrastructure*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007947:Leukemia, Megakaryoblastic, Acute / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D009030:Mosaicism; D012074:Remission Induction
chemical_list: D000677:Amsacrine; D003561:Cytarabine; D005047:Etoposide; D008942:Mitoxantrone; D003630:Daunorubicin
vernacular_title: Leucemia aguda mieloblástica 5q-. Remisión clínica y citogenética mediante quimioterapia intensiva.